Walgreens has agreed to a settlement of up to $350 million with the U.S. Department of Justice over accusations of illegally filling millions of opioid prescriptions over the past decade. The settlement, announced last Friday, mandates Walgreens to pay at least $300 million, with an additional $50 million due if the company undergoes a sale or merger before 2032. The DOJ’s complaint alleges that from August 2012 to March 2023, Walgreens pharmacists filled prescriptions despite obvious signs of invalidity and pushed for quick processing, ignoring substantial evidence of illegal prescriptions.
The settlement aims to close all opioid-related cases with various governmental bodies. Walgreens, facing declining market share and the closure of 1,200 stores, denies responsibility while still seeking to resolve legal disputes. The company’s compliance initiatives involve improved training and oversight for pharmacists regarding controlled substances. This settlement follows numerous similar lawsuits in the pharmaceutical industry, with over $50 billion in settlements related to the opioid crisis over the past eight years. The DOJ remains committed to holding pharmacies accountable in addressing the opioid epidemic.
Source link
